Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, Z. C.
Right arrow Articles by Caen, J. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Han, Z. C.
Right arrow Articles by Caen, J. P.

International Journal of Cell Cloning, Vol 8, 253-259, Copyright © 1990 by AlphaMed Press

ORIGINAL ARTICLES

Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III)

ZC Han, S Bellucci, A Walz, M Baggiolini and JP Caen
INSERM U.150, UA 334 CNRS, Institut des Vaisseaux et du Sang, Hopital Lariboisiere, Paris, France.

We have previously reported that human platelet factor 4 (PF4) and beta- thromboglobulin inhibit human megakaryocyte (meg) colony formation in vitro. Here, we report further findings concerning the effect of PF4 as well as another platelet-derived factor: connective tissue-activating peptide (CTAP-III). Addition of these factors (2.5-10 micrograms/ml) into normal marrow cultures resulted in a significant decrease of meg colonies, especially the mixed-meg colonies, BFU-meg and large CFU-meg, suggesting that they inhibit both proliferation and maturation of meg progenitor cells, with a predominant effect on earlier progenitor cells. Comparison of the effects of the two factors showed that their major effects were similar, with some difference in inhibitory degree. These results indicate that both PF4 and CTAP-III are potent inhibitors of meg colony formation and involved in negative autocrine regulation of megakaryocytopoiesis.


This article has been cited by other articles:


Home page
 BloodHome page
B. Scheuerer, M. Ernst, I. Durrbaum-Landmann, J. Fleischer, E. Grage-Griebenow, E. Brandt, H.-D. Flad, and F. Petersen
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages
Blood, February 15, 2000; 95(4): 1158 - 1166.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Riviere, F. Subra, K. Cohen-Solal, V. Cordette-Lagarde, R. Letestu, C. Auclair, W. Vainchenker, and F. Louache
Phenotypic and Functional Evidence for the Expression of CXCR4 Receptor During Megakaryocytopoiesis
Blood, March 1, 1999; 93(5): 1511 - 1523.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Z. C. Han, M. Lu, J. Li, M. Defard, B. Boval, N. Schlegel, and J. P. Caen
Platelet Factor 4 and Other CXC Chemokines Support the Survival of Normal Hematopoietic Cells and Reduce the Chemosensitivity of Cells to Cytotoxic Agents
Blood, April 1, 1997; 89(7): 2328 - 2335.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1990 by AlphaMed Press.